Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity

CD27 is an important co-stimulatory receptor of T cells that can potentially be exploited for immunotherapy. We developed a human IgG1 antibody that targets human CD27, and demonstrated its immunostimulatory and antineoplastic activity in various preclinical models. Currently, the antibody (1F5, CDX-1127) is being tested in patients affected by advanced malignancies.

[1]  L. Vitale,et al.  Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice , 2013, The Journal of Immunology.

[2]  C. Schürch,et al.  CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. , 2012, Cancer research.

[3]  S. Ansell,et al.  Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia , 2012, Clinical Cancer Research.

[4]  M. Moser,et al.  Role of CD27/CD70 pathway of activation in immunity and tolerance , 2011, Journal of leukocyte biology.

[5]  M. Glennie,et al.  Control of Established Melanoma by CD27 Stimulation Is Associated With Enhanced Effector Function and Persistence, and Reduced PD-1 Expression of Tumor Infiltrating CD8+ T Cells , 2010, Journal of immunotherapy.

[6]  H. Yagita,et al.  Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice. , 2010, Biochemical and biophysical research communications.

[7]  P. Reichardt,et al.  Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies , 2008, PloS one.

[8]  M. Glennie,et al.  Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation. , 2007, Blood.

[9]  M. Glennie,et al.  Eradication of lymphoma by CD 8 T cells following anti-CD 40 monoclonal antibody therapy is critically dependent on CD 27 costimulation , 2007 .

[10]  Michael Weller,et al.  Immune stimulatory effects of CD70 override CD70‐mediated immune cell apoptosis in rodent glioma models and confer long‐lasting antiglioma immunity in vivo , 2006, International journal of cancer.